Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 836.49 Million | USD 1245.25 Million | 4.52% | 2023 |
The global stigmasterol-rich plant sterols market size was worth around USD 836.49 million in 2023 and is predicted to grow to around USD 1,245.25 million by 2032 with a compound annual growth rate (CAGR) of roughly 4.52% between 2024 and 2032.
Stigmasterol is an unsaturated phytosterol. It belongs to the tetracyclic triterpenes class. Studies suggest that stigmasterol is the most common and one of the most important plant sterols found across a range of natural sources. It is mainly found in vegetable fats and plant-based oils.
The compound has been extensively researched to understand its pharmacological effects on living organisms. Stigmasterol-rich plant sterols have shown anti-osteoarthritis, anticancer, anti-diabetic, anti-inflammatory, antiparasitic, immunomodulatory, antibacterial, antifungal, and antioxidant properties.
These attributes have helped the industry gain significant growth momentum with large-scale and growing applications in several thriving end-user industries such as healthcare & pharmaceuticals, food & beverages, personal care & cosmetics, and others.
One of the key attributes of phytosterol, which makes stigmasterol highly popular across end-user industries, is that it mimics cholesterol in humans, thus making it an excellent food additive that aids in reducing bad cholesterol.
The increasing number of patients with high cholesterol levels and associated conditions will further impact the industry’s demand rate. However, limited awareness is expected to emerge as one of the leading growth inhibitors for the stigmasterol-rich plant sterols industry.
Rising number of patients with high cholesterol levels will drive the market demand rate
The global stigmasterol-rich plant sterol market is expected to grow due to the growing number of patients with high cholesterol levels. The condition is also known as hyperlipidemia, which leads to high levels of cholesterol in your blood and can be caused due to several factors.
For instance, one of the major reasons for a growing number of patients with hyperlipidemia is an inactive lifestyle. The increasing rate of desk-job workers with long working hours, along with changing consumer lifestyles, has resulted in an increased number of patients with cholesterol levels higher than normal.
In addition to this, hyperlipidemia is also caused by excessive alcohol drinking, unhealthy diet, and other diseases such as type 2 diabetes, kidney-related conditions, liver diseases, and polycystic ovary syndrome.
According to the World Heart Federation, around 39% of adults across the globe are living with high cholesterol. Such statistics are likely to drive the demand for plant sterols, especially stigmasterol since it can help in reducing bad cholesterol levels and improve good cholesterol in the body.
Increases demand for healthy food items, rise in food service industry to generate avenues for improved revenue
The growing trend of healthy eating in several parts of the world could be beneficial to the industry players during the forecast period. Stigmasterol-rich plant sterols-based food items are becoming widely popular among the masses.
Additionally, the growing food service industry, especially influenced by the emergence and surge in the food tourism sector, will further impact the demand rate in the global stigmasterol-rich plant sterols market.
For instance, European nations have registered a higher number of international tourists in the last decade. The majority of tourists travel to the country to try local cuisine, impacting the total revenue in the region.
Similarly, other nations have been influenced by the growth in the number of people traveling to experiment with global dietary solutions.
Lower consumer awareness and competition from alternate compounds will limit the market’s growth rate
The global industry for stigmasterol-rich plant sterols is projected to be restricted due to lower consumer awareness in the industry.
For instance, common people may be unaware of the specific advantages of incorporating plant sterols in dietary items. Moreover, the end-user industries are constantly experimenting with alternate solutions.
For instance, the food industry invests heavily in other compounds that help deal with overall health. Some of these alternatives include Omega-3 fatty acids, sitosterol-rich plant sterols, soy protein, rest yeast rice, and others.
Rising dietary supplements sector will generate extensive growth opportunities during the projection period
The global stigmasterol-rich plant sterols market is projected to generate growth opportunities due to the rising demand for dietary supplements. These are products that are consumed orally and are not a part of the regular diet.
Supplements are consumed along with everyday food items to meet the nutrition needs of individuals. The growing concerns over food adulteration and the availability of consumables with less than standard nutrients are encouraging more people to opt for dietary supplements.
On the other hand, certain medical conditions can force patients to consume supplemental nutrients for comprehensive well-being.
According to market research, the global dietary supplement market is expected to grow by over USD 250 billion during the projection period.
Applications in the healthcare industry may aid higher growth momentum in the industry
The healthcare and pharmaceutical industry is likely to deliver higher growth avenues for the stigmasterol-rich plant sterols industry players.
Rising investments in research around stigmasterol-rich plant sterols to be included in pharmaceutical products and healthcare items will assist in expanding product reach.
Moreover, experiments with novel modes of compound delivery in the form of drugs and medicines may also aid in higher growth momentum in the industry.
Fluctuations in raw material availability may challenge the market expansion rate
Concerns over fluctuations in raw material availability are projected to challenge the global industry for stigmasterol-rich plant sterols.
For instance, prices and volumes of essential main materials such as nuts, soybeans, and others may vary depending on weather conditions and geopolitical tension. Such factors could impact the total production rate of plant sterols.
The global stigmasterol-rich plant sterols market is segmented based on applications, source, and region.
Based on the applications, the global market segments are cosmetics & personal care, food & beverages, healthcare & pharmaceutical, and animal feed industry.
In 2023, the highest growth was observed in the food & beverages industry. Stigmasterol-rich plant sterols are used as food additives to improve the overall health quotient of food products.
Moreover, the rising demand for healthy food solutions will fuel the market demand rate in the future. The global functional food industry was valued at over USD 305 billion in 2022.
Based on the source, the stigmasterol-rich plant sterols industry segments are seeds, plants, medicinal herbs, nuts, vegetables, legumes, Calabar beans, unpasteurized milk, medicinal herbs, and others.
In 2023, the highest growth rate was listed in the seeds segment. Soybean, for instance, is one of the most common sources of generated sterols.
The rising production of good quality soybean and other seed-based alternatives such as rapeseed will aid segmental revenue. Soybean oil is known to contain around 250–500 mg of total plant sterols per 100 grams.
Report Attributes | Report Details |
---|---|
Report Name | Stigmasterol-Rich Plant Sterols Market |
Market Size in 2023 | USD 836.49 Million |
Market Forecast in 2032 | USD 1,245.25 Million |
Growth Rate | CAGR of 4.52% |
Number of Pages | 221 |
Key Companies Covered | Xi’an Healthful Biotechnology, ADM (Archer Daniels Midland), Advanced Organic Materials (AOM), Fenchem Biotek, DSM Nutritional Products, Matrix Fine Sciences, Enzymatic Deactivation, Cargill, Kausik Nutrition, DuPont (Danisco), Arboris, Vitae Caps, BASF, Raisio Group, Phytosterols Inc., and others. |
Segments Covered | By Applications, By Source, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America will dominate the global revenue during the projection period
The global stigmasterol-rich plant sterols market will be led by North America during the projection period. In 2023, the region accounted for nearly 33.57% of the total global revenue.
The US dominance in the regional market is influenced by several factors, such as a strong and technologically advanced agricultural sector along with higher demand for dietary supplements.
According to market research, over 75% of US citizens consume some form of dietary supplement. On the other hand, increasing research in anti-cancer compounds in the US healthcare sector is expected to generate significant growth opportunities for stigmasterol-rich plant sterols.
In September 2024, the US Department of Agriculture announced an investment plan of USD 121 million to be directed toward advanced research and studies, especially targeting organic agriculture and specialty crop production.
Asia-Pacific is an emerging region with substantial growth potential in the stigmasterol-rich plant sterols industry. As per market study, China is expected to grow at a CAGR of more than 5.61% during the forecast period.
The growing demand for plant-based nutritional products, along with growing initiatives by the regional government to promote the domestic agriculture industry, will fuel revenue in China. India is projected to grow at a CAGR of 3.85% by 2032.
The global stigmasterol-rich plant sterols market is led by players like:
By Applications
By Source
FrequentlyAsked Questions
Stigmasterol is an unsaturated phytosterol. It belongs to the tetracyclic triterpenes class.
The global stigmasterol-rich plant sterol market is expected to grow due to the growing number of patients with high cholesterol levels.
According to study, the global stigmasterol-rich plant sterols market size was worth around USD 836.49 million in 2023 and is predicted to grow to around USD 1,245.25 million by 2032.
The CAGR value of the stigmasterol-rich plant sterols market is expected to be around 4.52% during 2024-2032.
The global stigmasterol-rich plant sterols market will be led by North America during the projection period.
The global stigmasterol-rich plant sterols market is led by players like Xi’an Healthful Biotechnology, ADM (Archer Daniels Midland), Advanced Organic Materials (AOM), Fenchem Biotek, DSM Nutritional Products, Matrix Fine Sciences, Enzymatic Deactivation, Cargill, Kausik Nutrition, DuPont (Danisco), Arboris, Vitae Caps, BASF, Raisio Group and Phytosterols Inc.
The report explores crucial aspects of the stigmasterol-rich plant sterols market including a detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed